Adverse events116

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 116

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Abdominal Pain	Gastrointestinal disorders	DTaP-IPV-Hep B-PRP~T	131	1,411	131
other	Abdominal Pain	Gastrointestinal disorders	Tritanrix-Hep B/Hib™ + OPV	70	703	70
other	Diarrhoea	Gastrointestinal disorders	DTaP-IPV-Hep B-PRP~T	264	1,411	264
other	Diarrhoea	Gastrointestinal disorders	Tritanrix-Hep B/Hib™ + OPV	123	703	123
other	Solicited Vomiting Post-dose 1	Gastrointestinal disorders	DTaP-IPV-Hep B-PRP~T	230	1,410	230
other	Solicited Vomiting Post-dose 1	Gastrointestinal disorders	Tritanrix-Hep B/Hib™ + OPV	120	703	120
other	Solicited Injection site Erythema Post-dose 3	General disorders	DTaP-IPV-Hep B-PRP~T	587	1,410	587
other	Solicited Injection site Erythema Post-dose 3	General disorders	Tritanrix-Hep B/Hib™ + OPV	340	703	340
other	Injection Site Haemorrhage	General disorders	DTaP-IPV-Hep B-PRP~T	39	1,411	39
other	Injection Site Haemorrhage	General disorders	Tritanrix-Hep B/Hib™ + OPV	63	703	63
other	Injection Site Nodule	General disorders	DTaP-IPV-Hep B-PRP~T	81	1,411	81
other	Injection Site Nodule	General disorders	Tritanrix-Hep B/Hib™ + OPV	79	703	79
other	Solicited Injection Site Pain Post-dose 1	General disorders	DTaP-IPV-Hep B-PRP~T	831	1,410	831
other	Solicited Injection Site Pain Post-dose 1	General disorders	Tritanrix-Hep B/Hib™ + OPV	574	703	574
other	Solicited Injection Site Swelling Post-dose 3	General disorders	DTaP-IPV-Hep B-PRP~T	400	1,408	400
other	Solicited Injection Site Swelling Post-dose 3	General disorders	Tritanrix-Hep B/Hib™ + OPV	323	703	323
other	Solicited Irritability post-dose 1	General disorders	DTaP-IPV-Hep B-PRP~T	945	1,410	945
other	Solicited Irritability post-dose 1	General disorders	Tritanrix-Hep B/Hib™ + OPV	576	703	576
other	Solicited Pyrexia Post-dose 2	General disorders	DTaP-IPV-Hep B-PRP~T	675	1,411	675
other	Solicited Pyrexia Post-dose 2	General disorders	Tritanrix-Hep B/Hib™ + OPV	457	703	457

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00313911/events

API reference For AI assistants

Adverse events116

Sources 3

Read this list from software.